Medindia

X

U.S. FDA Clears MagVita TMS Therapy System for Major Depressive Disorder

by Vishnuprasad on  September 3, 2015 at 6:32 PM Medical Gadgets   - G J E 4
The U.S. Food and Drug Administration (FDA) has approved the MagVita transcranial magnetic stimulation (TMS) therapy system for the treatment of major depressive disorder.

The TMS system was developed by MagVenture, a medical device company, established in 2007.
 U.S. FDA Clears MagVita TMS Therapy System for Major Depressive Disorder
U.S. FDA Clears MagVita TMS Therapy System for Major Depressive Disorder
Advertisement

Low operating costs coupled with an easy administration and equal efficacy rates as other cleared devices makes the MagVita TMS Therapy system the optimal choice for both doctors and patients.

Advertisement
The system is recommended for the treatment of major depressive disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.

The system was the first system to be cleared in the EU and has a proven track-record of treatment efficacy, usability, and quality.

Major depressive disorder is also known as clinical depression, major depression, unipolar depression, or unipolar disorder; or as recurrent depression in the case of repeated episodes.

The disorder is a mental disorder characterized by a pervasive and persistent low mood that is accompanied by low self-esteem and by a loss of interest in normally enjoyable activities.



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All